Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Clinical Cancer Research|2018Cited by 95
EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome ReprogrammingRemi Adelaiye‐Ogala, Роберто Пили, Justin A. Budka et al.|Cancer Research|2017Cited by 74
Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell CarcinomaNur P. Damayanti, Роберто Пили, Justin A. Budka et al.|Unknown|2018Cited by 0
Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancerMay Elbanna, Роберто Пили, Justin A. Budka et al.|Cancer Research|2019Cited by 0
Supplementary Table 2 from EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome ReprogrammingRemi Adelaiye‐Ogala, Роберто Пили, Justin A. Budka et al.|Unknown|2023Cited by 0